Skip to main content
Advertisement
Advertisement

ORMP

ORMP logo

Oramed Pharmaceuticals Inc.

4.79
USD
Sponsored
+0.07
+1.48%
Sep 24, 15:59 UTC -4
Closed
exchange

Pre-Market

4.79

0.00
0.00%

ORMP Earnings Reports

Positive Surprise Ratio

ORMP beat 13 of 17 last estimates.

76%

Next Report

Date of Next Report
Nov 11, 2026
Estimate for Q3 26 (Revenue/ EPS)
--
/
$0.43
Implied change from Q2 26 (Revenue/ EPS)
--
/
-76.63%
Implied change from Q3 25 (Revenue/ EPS)
--
/
-61.61%

Oramed Pharmaceuticals Inc. earnings per share and revenue

On Aug 10, 2026, ORMP reported earnings of 1.84 USD per share (EPS) for Q2 26, beating the estimate of 0.43 USD, resulting in a 319.52% surprise. Revenue reached --, compared to an expected --, with a 0.00% difference. The market reacted with a +1.19% price change (close before vs. close after earnings).
Looking ahead to Q3 26, -- analysts forecast an EPS of 0.43 USD, with revenue projected to reach -- USD, implying an decrease of -76.63% EPS, and increase of 0.00% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

logo
Kestra Medical Technologies, Ltd. Common Stock
Report Date
Sep 14, 2026 For Q1 27
Estimate
-$0.62
Actual
-$0.65
Surprise
-3.47%
logo
High Tide Inc. Common Shares
Report Date
Sep 14, 2026 For Q3 26
Estimate
$0.01
Actual
$0.12
Surprise
+1,088.12%
FAQ
For Q2 2026, Oramed Pharmaceuticals Inc. reported EPS of $1.84, beating estimates by 319.52%, and revenue of $0.00, 0% as expectations.
The stock price moved up 1.19%, changed from $4.20 before the earnings release to $4.25 the day after.
The next earning report is scheduled for Nov 11, 2026.
Based on -- analysts, Oramed Pharmaceuticals Inc. is expected to report EPS of $0.43 and revenue of -- for Q3 2026.
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement